Purchase Order 36C26326P0075

Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leading provider of transcatheter and surgical cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 on October 31, 2025. The contract, designated as a TAVR (Transcatheter Aortic Valve Replacement) procurement, is not set-aside and will be performed in Minneapolis, Minnesota, with an ultimate completion date of December 30, 2025. As the sole manufacturer of the specialized heart valve products required, Edwards Lifesciences LLC serves as the prime contractor with no identified subcontractors in this award.

This purchase order represents a typical transactional award within the Department of Veterans Affairs' broader effort to supply advanced cardiovascular medical technologies to the veteran population across its nationwide network. The Veterans Integrated Service Network 23 procurement supports the VA's mission to provide specialized surgical care, with Edwards Lifesciences LLC maintaining an established federal contracting relationship that includes both smaller purchase orders and larger indefinite delivery contracts valued up to $2.5 million. This particular TAVR device award enables the VA facility to maintain inventory of short shelf-life cardiovascular implants necessary for transcatheter aortic valve replacement procedures.